EUVIMEDEUVIMED entdecken
Crossref

A Digital Score Based on Circulating-Tumor-Cells-Derived mRNA Quantification and Machine Learning for Early Colorectal Cancer Detection

Cheng Li iD, Zhili Wang iD, Pi Ding iD, Zeyang Zhou, Ruidong Chen, Yunyun Hu, Kui Zhao, Wei Peng, Xiaodong Yang, Na Sun iD, Renjun Pei iD

ACS Nano · 20.05.2025 · 19 (19) · 18117-18128

DOI: 10.1021/acsnano.4c15056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 07.05.2025. Verfasst von Cheng Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplastic Cells, Circulating, Early Detection of Cancer, Machine Learning. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of China, Science and Technology Foundation of Suzhou, Youth Innovation Promotion Association CAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) serve as valuable biomarkers in tumor circulation, carrying essential primary tumor information. The purification of CTCs from peripheral blood samples and the analysis of their characteristic molecules enable the detection of tumors at an early stage. The noninvasive, continuous, real-time dynamic monitoring provides a promising solution for the timely diagnosis of colorectal cancer (CRC). In this study, we developed a minimally invasive method for CRC early detection to enable accurate screening in a friendly manner for individuals who generally require colonoscopy. The dual-antibody (i.e., anti-EpCAM and anti-EGFR) modified antifouling hydrogel-coated magnetic nanoparticles (pSBMA-MNPs) were prepared for efficient and specific CTC purification. Then, the quantification of 6 RNA transcripts in purified CRC CTCs was performed via droplet digital PCR (ddPCR), and a CRC score was calculated using an extreme gradient boosting model to distinguish CRC from colon polyps and adenomas. A pilot study was conducted to evaluate the clinical potential of the CRC CTC RNA assay in a training cohort (n = 101) and an independent test cohort (n = 65), achieving a diagnostic accuracy of 91.0% in the whole cohort, significantly outperforming serum CEA, CA125, and CA199. Subgroup analysis across CRC stage, age, and tumor location of patients was also performed, and the CRC score exhibited robust performance, demonstrating commendable diagnostic efficacy for CRC detection and promising application in friendly screening individuals that really require colonoscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNeoplastic Cells, CirculatingEarly Detection of CancerMachine LearningRNA, MessengerHumansMaleFemaleBiomarkers, TumorMiddle AgedAgedMagnetite NanoparticlesHydrogels

Stichwörter der Autor:innen

cancer diagnosiscirculating tumor cellscolon polyps and adenomacolorectal cancermRNA quantificationmachine learning

Substanzen

RNA, MessengerBiomarkers, TumorMagnetite NanoparticlesHydrogels

Autor:innen und Institutionen

  • CAS Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China.
  • School of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei 230026, China.
  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Cancer Institute, Suzhou Medical College, Soochow University, Suzhou 215004, China.
  • National Center of Technology Innovation for Biopharmaceuticals, Suzhou 215123, China.

ORCID-Profile: Cheng Li, Zhili Wang, Pi Ding, Na Sun, Renjun Pei

Förderung

  • Natural Science Foundation of China
  • Science and Technology Foundation of Suzhou
  • Youth Innovation Promotion Association CAS
  • Science and Technology Foundation of Jiangsu Province
  • Provincial-level Talent Program for National Center of Technology Innovation for Biopharmaceuticals

Zitieren

APA

Li, C., Wang, Z., Ding, P., Zhou, Z., Chen, R., Hu, Y., Zhao, K., Peng, W., Yang, X., Sun, N., & Pei, R. (2025). A Digital Score Based on Circulating-Tumor-Cells-Derived mRNA Quantification and Machine Learning for Early Colorectal Cancer Detection. ACS Nano, 19(19), 18117-18128. https://doi.org/10.1021/acsnano.4c15056

Vancouver

Li C, Wang Z, Ding P, Zhou Z, Chen R, Hu Y, et al. A Digital Score Based on Circulating-Tumor-Cells-Derived mRNA Quantification and Machine Learning for Early Colorectal Cancer Detection. ACS Nano. 2025;19(19):18117-18128. doi:10.1021/acsnano.4c15056

BibTeX
@article{Li2025,
  author = {Li, Cheng and Wang, Zhili and Ding, Pi and Zhou, Zeyang and Chen, Ruidong and Hu, Yunyun and Zhao, Kui and Peng, Wei and Yang, Xiaodong and Sun, Na and Pei, Renjun},
  title = {A Digital Score Based on Circulating-Tumor-Cells-Derived mRNA Quantification and Machine Learning for Early Colorectal Cancer Detection},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {19},
  pages = {18117--18128},
  doi = {10.1021/acsnano.4c15056}
}
Kostenlos starten →